Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.670
-0.020 (-1.18%)
Feb 4, 2026, 4:00 PM EST - Market closed
Inovio Pharmaceuticals Revenue
Inovio Pharmaceuticals had revenue of $182.34K in the twelve months ending September 30, 2025, down -10.36% year-over-year. In the year 2024, Inovio Pharmaceuticals had annual revenue of $217.76K, down -73.83%.
Revenue (ttm)
$182.34K
Revenue Growth
-10.36%
P/S Ratio
629.24
Revenue / Employee
$1,361
Employees
134
Market Cap
114.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 217.76K | -614.25K | -73.83% |
| Dec 31, 2023 | 832.01K | -9.43M | -91.89% |
| Dec 31, 2022 | 10.26M | 8.49M | 478.23% |
| Dec 31, 2021 | 1.77M | -5.64M | -76.05% |
| Dec 31, 2020 | 7.41M | 3.30M | 80.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 142.53M |
| MacroGenics | 127.63M |
| Spero Therapeutics | 40.55M |
| Verrica Pharmaceuticals | 30.83M |
| Korro Bio | 7.37M |
| Cardiff Oncology | 501.00K |
| Genelux | 8.00K |
INO News
- 25 days ago - Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 - Seeking Alpha
- 5 weeks ago - FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) - PRNewsWire
- 6 weeks ago - INOVIO Reports Inducement Grant Under Inducement Plan - PRNewsWire
- 2 months ago - Inovio Pharmaceuticals, Inc. (INO) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - INOVIO to Participate in December Investor Conferences - PRNewsWire
- 3 months ago - Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress - Seeking Alpha
- 3 months ago - INOVIO Announces Pricing of $25 Million Public Offering - PRNewsWire
- 3 months ago - Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript - Seeking Alpha